Our Dedicated  plants  manufacture  APIs, Controlled Release  formulations, Tablets,  Capsules, Liquid orals, Topical  preparations and Nutraceuticals. Most of our speciality   products    are    manufactured   using   the unique DRCM Technologythat provides the advantage of “Once a day dosage convenience”

Being a WHO GMP certified manufacturing company, efforts   are  currently    being   channelised    towards  obtaining approvals from MCA(UK),TGA (Australia), MCC (S. Africa) for  formulations. ANVISA – Brazil and  the  Regulatory  Authorities  of African Countries have already approved our manufacturing plants.

A  specialised  range  of  APIs  are  manufactured  for captive  consumption  and   for  clients  from  Europe, Africa and the South East Asian countries.A promising response from Latin American manufacturers for APIs from  our stables  has encouraged us to cater to South American countries.